Search results for: 'cancer market'

Liquid biopsy (CTCs and ctDNAs) is slowly gaining momentum in clinical care given its advantages over the traditional tissue-based gold standard methods. Short-term applications in cancer care range from risk assessment to cancer recurrence monitoring. Despite the proven advantages, there is still a significant number of barriers to adoption such a...

Business-to-business (B2B) influencer marketing has the potential to generate $11.7 billion in revenue by the end of 2022, with more than 38% of B2B companies currently exploring influencer marketing as a new lead-generation avenue. Influencer marketing is set to become a mainstream approach for B2B companies that are looking to tap into the power ...

The report provides an indepth analysis of each trend, outlining market demands, drivers and restraints, growth opportunities, and use cases. This will help vendors analyze the market, evaluate their market positioning, and take appropriate action to become global leaders.--BEGIN PROMO--Research Scope This study examines the market scenario and ...

Marketing is changing rapidly. Customers are no longer driven by advertisements; instead, their purchase decisions are influenced by their favorite content creators. Moreover, owing to the growing time spent online and the increasing amount of content, the creator economy is changing the way marketing is done. In this study, Frost & Sullivan exp...

06 Jul 2017  |  Asia Pacific  |  Market Research

Growth Opportunities in APAC Oncology Diagnostics Market, Forecast to 2021

Innovation, Technology Integration, and New Customer Segments to Drive New Business Growth

Infographics

×

There is high growth in the Asia-Pacific (APAC) oncology diagnostics market due to increasing incidence of cancer and the drastic reduction in incidence age owing to a plethora of reasons in the regional market. The major drivers for the APAC cancer diagnostics market are increase in adoption of technology platforms, access to targeted cancer thera...

24 Oct 2018  |  North America  |  Market Research

Growth Opportunities in the Global Cell Therapy Market, Forecast to 2025

A Robust Product Pipeline Creating Opportunities for Ground-breaking Combination Therapies is Set to Revolutionize the Global Cell Therapy Market

Infographics

×

Key Issues Addressed

The global pharmaceuticals industry is continuously evolving to meet the requirements of a changing disease landscape. With the increasing prevalence of chronic infectious diseases and cancer, market needs are shifting from traditional small molecules to novel large molecule therapies, with cell therapies dominating the space. This study presents a...

27 Nov 2017  |  North America  |  Market Research

Growth Opportunities in the Global Digital Pathology Market, Forecast to 2021

New Business Models and More FDA Approvals of WSI Scanners for Primary Diagnostics are Set to Boost Growth of Digital Pathology

Infographics

×

Key Issues Addressed

Shortage of pathologists and the rise in new cancer cases are the key drivers for the adoption of digital pathology solutions globally. Digital pathology enhances the productivity of pathologists by 10% to 15%, thereby improving the overall efficiency of healthcare providers. Digital pathology solutions find the best fit in oncology care. Accordin...

07 Feb 2018  |  Global  |  Market Research

Growth Opportunities in the Calibration and Repair Services Market, Forecast to 2022

Market Consolidation and Technological Expertise to Accelerate Growth in a Transforming Market

Infographics

×

The calibration and repair services market in North America and Europe is anticipated to reach $3.98 billion by 2022, driven by the increase in quality awareness, greater adoption of metrology in the manufacturing process, and tightening of regulations by calibration regulatory authorities across the world. This market is expected to grow rapidly w...

Patent expiration and increased use of traditional generic drugs are leading to a shift of focus in the pharmaceutical industry toward investment in specialty drugs and high growth areas such as biosimilars. Expensive biopharmaceuticals are largely used for life-saving disorders such as cancer and diabetes, the incidence of which is increasing with...